Antimicrobial resistance: is it really that bad?

Scott F Dowell1

  • 1International Emerging Infections Program, US Centers for Disease Control and Prevention and Thai Ministry of Public Health, Building 7, Department of Disease Control, Ministry of Public Health, Tivanon Road, Nonthaburi, Thailand.

Insights

Antimicrobial resistance remains a substantial global threat, complicating pediatric infectious disease treatment and limiting therapeutic options. Despite some successful interventions, untreatable infections and rising costs persist, particularly in developing nations.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Public Health

Background:

  • Antimicrobial resistance (AMR) is a persistent global health concern, frequently discussed in pediatric and infectious disease literature.
  • While some progress has been made in combating AMR, such as reduced unnecessary prescribing and new agent development, the problem remains substantial.
  • Skepticism regarding dire predictions of untreatable infections exists, yet the reality of multiply resistant organisms and escalating treatment costs is undeniable.

Purpose of the Study:

  • To highlight the ongoing and significant challenge of antimicrobial resistance in pediatric care.
  • To underscore the impact of AMR on treatment options and costs for infectious diseases.
  • To provide a balanced perspective on the successes and persistent challenges in addressing antimicrobial resistance.

Main Methods:

  • Review of current literature and clinical observations regarding antimicrobial resistance in pediatric populations.
  • Analysis of trends in prescribing practices, treatment modifications, and availability of new antimicrobial agents.
  • Assessment of the economic and clinical impact of resistant organisms on patient care.

Main Results:

  • Despite efforts to curb unnecessary antibiotic use and introduce new treatments, dangerous multiply resistant organisms continue to emerge.
  • The costs associated with treating infections caused by resistant bacteria are escalating significantly.
  • In many developing countries, antimicrobial resistance has rendered previously treatable infections untreatable, while in the US, it complicates routine pediatric practice.

Conclusions:

  • Antimicrobial resistance continues to pose a serious threat to pediatric health worldwide, complicating treatment and limiting therapeutic choices.
  • Effective strategies are needed to address the ongoing spread of resistance and its profound impact on patient outcomes and healthcare costs.
  • Continued vigilance, research, and implementation of antimicrobial stewardship programs are crucial in managing this evolving public health crisis.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...